Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000921895-24-001850
Filing Date
2024-08-15
Accepted
2024-08-15 20:26:33
Documents
1

Document Format Files

Seq Description Document Type Size
1 sc13ga110871ttoo_08152024.htm SC 13G/A 77736
  Complete submission text file 0000921895-24-001850.txt   79378
Mailing Address C/O THE WOLFSON GROUP ONE STATE STREET PLAZA 29TH FLOOR NEW YORK NY 10004
Business Address C/O THE WOLFSON GROUP ONE STATE STREET PLAZA 29TH FLOOR NEW YORK NY 10004 212-412-9103
New Dimensions Trading (Filed by) CIK: 0001381550 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 101 HARTWELL AVENUE LEXINGTON MA 02421
Business Address 101 HARTWELL AVENUE LEXINGTON MA 02421 781-457-1200
T2 Biosystems, Inc. (Subject) CIK: 0001492674 (see all company filings)

EIN.: 204827488 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88541 | Film No.: 241213929
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)